Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon-gamma: a key immunoregulatory lymphokine

J G Williams1, G J Jurkovich, R V Maier

  • 1Department of Surgery, University of Washington School of Medicine, Harborview Medical Center, Seattle 98195.

The Journal of Surgical Research
|January 1, 1993
PubMed
Summary

Interferon-gamma (IFN-γ) shows potential for treating infections in immunocompromised patients. However, its use in immune-competent individuals may cause adverse reactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective non-operative management in 25 737 patients with penetrating abdominal injuries (Br J Surg 2011; 99(Suppl 1): 157-167).

The British journal of surgery·2012
Same author

Time factors associated with CT scan usage in trauma patients.

European journal of radiology·2008
Same author

Pre-operative assessment of anal fistulas using endoanal ultrasound.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2003
Same author

Upper airways abnormalities and tracheal problems in Morquio's disease.

Thorax·2003
Same author

Clarifications: open access follow up for inflammatory bowel disease.

BMJ (Clinical research ed.)·2002
Same author

Roadrunner to the rescue.

Annals of the Royal College of Surgeons of England·2002

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pharmacology

Background:

  • Interferon-gamma (IFN-γ) plays a crucial role in host defense against various inflammatory insults.
  • Preclinical data suggest therapeutic applications for IFN-γ, particularly in immunocompromised states.

Purpose of the Study:

  • To review the in vitro and in vivo mechanisms of interferon-gamma.
  • To evaluate the potential clinical utility of interferon-gamma in specific patient populations.
  • To highlight safety considerations for interferon-gamma administration.

Main Methods:

  • Literature review of in vitro and animal studies on interferon-gamma.
  • Analysis of existing data on interferon-gamma's biological actions.
  • Clinical considerations for interferon-gamma use.

Related Experiment Videos

Main Results:

  • Interferon-gamma demonstrates significant immunomodulatory and anti-infective properties in experimental models.
  • Evidence supports the potential benefits of interferon-gamma for immunocompromised patients facing infections.

Conclusions:

  • Interferon-gamma holds promise as a therapeutic agent, especially for infections in immunocompromised individuals.
  • Caution is advised regarding interferon-gamma administration in immunocompetent hosts due to potential adverse effects.